Stem Cells Archives | Page 146 of 201

Nohla Therapeutics to Acquire Clinical Grade Cord Blood Units from LifeSouth for Expanded HSC Products

October 21, 2016 By Cade Hildreth, Founder & President Leave a Comment

Nohla Therapeutics has signed an exclusive supply agreement with LifeSouth Community Blood Centers headquartered in Gainesville, Florida. Under this agreement, LifeSouth’s cord blood banking program will supply Nohla Therapeutics with clinical grade cord blood units that will be used in the production process for the Company’s expanded hematopoietic stem and progenitor cell (HSC/HPC) products. [Read more…]

Cynata’s MSC Technology Demonstrates Significant Efficacy in Preclinical Asthma Study

October 20, 2016 By Cade Hildreth, Founder & President Leave a Comment

• Data suggests Cynata’s unique Cymerus™ iPSC-generated MSCs may have potential clinical use as a treatment for asthma

• Intranasal administration of Cymerus™ MSCs completely normalised airway hyperresponsiveness in a mouse model of asthma [Read more…]

How are Stem Cells Regulated by the FDA?

October 13, 2016 By Cade Hildreth, Founder & President 6 Comments

On September 12-13^th, 2016, the FDA hosted a public hearing to review draft guidances pertaining to the FDA regulation of stem cells.

More specifically, the hearing addressed the regulation of human cell and tissue-based products (HCT/Ps), defined by the FDA in § 1271.3(d) as “articles containing or consisting of human cells or tissues that are intended for implantation, transplantation, infusion, or transfer into a human recipient.” [Read more…]

Americord Registry Launches Pricing Calculator for Cord Blood Banking Services

October 13, 2016 By Cade Hildreth, Founder & President Leave a Comment

NEW YORK, New York — Americord, the fastest growing cord blood bank in the country, and a leader in the advancement of umbilical cord blood, cord tissue, and placenta tissue banking, announces the launch of its Cord Blood Banking Pricing Calculator. [Read more…]

Pall Corporation and RoosterBio to Co-Market Mesenchymal Stem/Stromal Cells and Bioreactors

October 5, 2016 By Cade Hildreth, Founder & President Leave a Comment

The agreement will encompass a co-development and marketing partnership.

RoosterBio, “Radically Changing the Use of Stem Cells”

OCTOBER 05, 2016 –Pall Corporation, a global leader in bioprocess equipment and disposables, announced the signing of a commercial collaboration agreement with RoosterBio Inc, an innovative adult stem cell technology company. The agreement will encompass a co-development and marketing partnership, delivering complete solutions for industrial-scale bioreactor expansion of human Mesenchymal Stem/Stromal Cells (hMSCs). [Read more…]